Cohort Studyhigh evidence
Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: multi-target trial emulation study.
BMJ open·July 21, 2026·PMID 42481079
Why it mattersAlcohol use disorder is common and undertreated, and existing pharmacotherapies have limited uptake. These findings suggest GLP-1 receptor agonists may reduce severe alcohol-related events, offering a potential dual-benefit option for patients with comorbid metabolic conditions.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled